CoChat

Age-related change in brain metabolite abnormalities in autism: a meta-analysis of proton magnetic resonance spectroscopy studies

Open access
Aoki, Y, Kasai, K, Yamasue, H · 2012 · Translational Psychiatry
Cited by 85

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Abnormal trajectory of brain development has been suggested by previous structural magnetic resonance imaging and head circumference findings in autism spectrum disorders (ASDs); however, the neurochemical backgrounds remain unclear. To elucidate neurochemical processes underlying aberrant brain growth in ASD, we conducted a comprehensive literature search and a meta-analysis of (1)H-magnetic resonance spectroscopy ((1)H-MRS) studies in ASD. From the 22 articles identified as satisfying the criteria, means and s.d. of measure of N-acetylaspartate (NAA), creatine, choline-containing compounds, myo-Inositol and glutamate+glutamine in frontal, temporal, parietal, amygdala-hippocampus complex, thalamus and cerebellum were extracted. Random effect model analyses showed significantly lower NAA levels in all the examined brain regions but cerebellum in ASD children compared with typically developed children (n=1295 at the maximum in frontal, P<0.05 Bonferroni-corrected), although there was no significant difference in metabolite levels in adulthood. Meta-regression analysis further revealed that the effect size of lower frontal NAA levels linearly declined with older mean age in ASD (n=844, P<0.05 Bonferroni-corrected). The significance of all frontal NAA findings was preserved after considering between-study heterogeneities (P<0.05 Bonferroni-corrected). This first meta-analysis of (1)H-MRS studies in ASD demonstrated robust developmental changes in the degree of abnormality in NAA levels, especially in frontal lobes of ASD. Previously reported larger-than-normal brain size in ASD children and the coincident lower-than-normal NAA levels suggest that early transient brain expansion in ASD is mainly caused by an increase in non-neuron tissues, such as glial cell proliferation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/tp.2011.65

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 50

  1. Frith U, Happe F, Siddons F . Autism and theory of mind in everyday life. Soc Dev 1994; 3: 108–124. · DOI · Paper page
  2. Frith U, Happe F . Language and communication in autistic disorders. Phil Trans R Soc B Biol Sci 1994; 346: 97–104. · DOI · Paper page
  3. Redcay E, Courchesne E . When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry 2005; 58: 1–9. · DOI · Paper page
  4. Schumann CM, Nordahl CW . Bridging the gap between MRI and postmortem research in autism. Brain Res 2011; 1380: 175–186. · DOI · Paper page
  5. Courchesne E, Pierce K, Schumann CM, Redcay E, Buckwalter JA, Kennedy DP et al. Mapping early brain development in autism. Neuron 2007; 56: 399–413. · DOI · Paper page
  6. Kato T, Inubushi T . Magnetic resonance spectroscopy in affective disorders. J Neuropsychiatry Clin Neurosci 1998; 10: 133–147. · DOI
  7. Clarke CE, Lowry M, Horsman A . Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy. Mov Disord 1997; 12: 297–301. · doi:10.1002/mds.870120306
  8. Ross B . Magnetic resonance spectroscopy of the human brain. Anat Rec 2001; 265: 54–84. · DOI · Paper page
  9. Moore C, Breeze J, Kukes T, Rose S . Effects of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 1999; 45: 1197–1202. · DOI
  10. Devito T, Drost D, Neufeld R, Rajakumar N, Pavlosky W, Williamson P et al. Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 2007; 61: 465–473. · DOI
  11. Friedman S, Shaw D, Artru A, Richards T . Regional brain chemical alterations in young children with autism spectrum disorder. Neurology 2003; 60: 100–107. · DOI · Paper page
  12. Levitt J, O’NEILL J, Blanton R, Smalley S, Fedale D, McCracken JT et al. Proton magnetic resonance spectroscopic imaging of the brain in childhood autism. Biol Psychiatry 2003; 54: 1355–1366. · DOI
  13. Murphy D, Critchley H, Schmitz N, McAlonan G, Amelsvoort TV, Robertson D et al. Asperger syndrome: a proton magnetic resonance spectroscopy study of brain. Arch Gen Psychiatry 2002; 59: 885–891. · DOI · Paper page
  14. O’Brien FM, Page L, O’Gorman RL, Bolton P, Sharma A, Baird G et al. Maturation of limbic regions in Asperger syndrome: a preliminary study using proton magnetic resonance spectroscopy and structural magnetic resonance imaging. Psychiatry Res 2010; 184: 77–85. · DOI
  15. Page L, Daly E, Schmitz N, Simmons A, Toal F, Deeley Q et al. In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry 2006; 163: 2189–2192. · DOI · Paper page
  16. Oner O, Devrimci-Ozguven H, Oktem F, Yagmurlu B, Baskak B, Munir KM . Proton MR spectroscopy: higher right anterior cingulate N-acetylaspartate/choline ratio in Asperger syndrome compared with healthy controls. Am J Neuroradiol 2007; 28: 1494–1498. · DOI
  17. Corrigan NM, Shaw DWW, Richards TL, Estes AM, Friedman SD, Petropoulos H et al. Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder. J Autism Dev Disord 2012; 42: 105–115. · DOI
  18. Bernardi S, Anagnostou E, Shen J, Kolevzon A, Buxbaum JD, Hollander E et al. In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Res 2011; 1380: 198–205. · DOI · Paper page
  19. Suzuki K, Nishimura K, Sugihara G, Nakamura K, Tsuchiya KJ, Matsumoto K et al. Metabolites alteration in the hippocampus of high-functioning adult subjects with autism. Int J Neuropsychopharm 2010; 13: 529–534. · DOI
  20. Mori K . Iryoteki-taio. No To Hattatsu 2010; 42: 199–203.
  21. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 2008–2012. · DOI · Paper page
  22. Weinberger DR . Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660–669. · DOI · Paper page
  23. Endo T, Shioiri T, Kitamura H, Kimura T, Endo S, Masuzawa N et al. Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders. Biol Psychiatry 2007; 62: 1030–1037. · DOI
  24. Gabis L, Huang W, Azizian A, DeVincent C, Tudorica A, Kesner-Baruch Y et al. 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders. J Child Neurol 2008; 23: 766–774. · DOI · Paper page
  25. Higgins J, Green S . Cochrane Handbook for Systematic Reviews of Interventions. Wiley: Chichester, UK, 2008. · DOI · Paper page
  26. Chugani DC, Sundram BS, Behen M, Lee ML, Moore GJ . Evidence of altered energy metabolism in autistic children. Prog Neuro-Psychopharmacol Biol Psychiat 1999; 23: 635–641. · DOI · Paper page
  27. Fayed N, Modrego P . Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Acad Radiol 2005; 12: 566–569. · DOI
  28. Friedman S, Shaw D, Artru A, Dawson G, Petropoulos H, Dager S . Gray and white matter brain chemistry in young children with autism. Arch Gen Psychiatry 2006; 63: 786–794. · DOI · Paper page
  29. Fujii E, Mori K, Miyazaki M, Hashimoto T, Harada M, Kagami S . Function of the frontal lobe in autistic individuals: a proton magnetic resonance spectroscopic study. J Med Invest 2010; 57: 35–44. · DOI
  30. Hashimoto T, Tayama M, Miyazaki M, Yoneda Y, Yoshimoto T, Harada M et al. Differences in brain metabolites between patients with autism and mental retardation as detected by in vivo localized proton magnetic resonance spectroscopy. J Child Neurol 1997; 12: 91–96. · DOI
  31. Hisaoka S, Harada M, Nishitani H, Mori K . Regional magnetic resonance spectroscopy of the brain in autistic individuals. Neuroradiology 2001; 43: 496–498. · DOI
  32. Otsuka H, Harada M, Mori K, Hisaoka S, Nishitani H . Brain metabolites in the hippocampus-amygdala region and cerebellum in autism: an 1 H-MR spectroscopy study. Neuroradiology 1999; 41: 517–519. · DOI
  33. Vasconcelos MM, Brito AR, Domingues RC, Cruz Jr LCH, Werner Jr J, Gonçalves JP . Proton magnetic resonance spectroscopy in school-aged autistic children. J Neuroimaging 2008; 18: 288–295. · DOI
  34. Kleinhans N, Schweinsburg B, Cohen D, Müller R, Courchesne E . N-acetyl aspartate in autism spectrum disorders: regional effects and relationship to fMRI activation. Brain Res 2007; 1162: 85–97. · DOI
  35. Kleinhans NM, Richards T, Weaver KE, Liang O, Dawson G, Aylaward E . Biochemical correlates of clinical impairment in high functioning autism Asperger's disorder. J Autism Dev Disord 2009; 39: 1079–1086. · DOI
  36. Hardan A, Minshew NJ, Melhem NM, Srihari S, Jo B, Bansal R et al. An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res 2008; 163: 97–105. · DOI
  37. Wang L, Mottron L, Peng D, Berthiaume C, Dawson M . Local bias and local-to-global interference without global deficit: a robust finding in autism under various conditions of attention, exposure time, and visual angle. Cogn Neuropsychol 2007; 24: 550–574. · DOI · Paper page
  38. Lombardo MV, Chakrabarti B, Bullmore ET, Sadek SA, Pasco G, Wheelwright SJ et al. Atypical neural self-representation in autism. Brain 2010; 133: 611–624. · DOI · Paper page
  39. Nordahl CW, Dierker D, Mostafavi I, Schumann CM, Rivera SM, Amaral DG et al. Cortical folding abnormalities in autism revealed by surface-based morphometry. J Neurosci 2007; 27: 11725–11735. · DOI · Paper page
  40. Yamasaki S, Yamasue H, Abe O, Suga M, Yamada H, Inoue H et al. Reduced gray matter volume of pars opercularis is associated with impaired social communication in high-functioning autism spectrum disorders. Biol Psychiatry 2010; 68: 1141–1147. · DOI
  41. Castelli F, Frith C, Happé F, Frith U . Autism, Asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes. Brain 2002; 125: 1839–1849. · DOI · Paper page
  42. Pelphrey KA, Morris JP, McCarthy G . Neural basis of eye gaze processing deficits in autism. Brain 2005; 128: 1038–1048. · DOI · Paper page
  43. Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD . N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol 2002; 51: 51–58. · DOI · Paper page
  44. Urenjak J, Williams S, Gadian D . Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13: 981–989. · DOI · Paper page
  45. Jessen KR . Glial cells. Int J Biochem Cell Biol 2004; 36: 1861–1867. · DOI · Paper page
  46. Goebell E, Fiehler J, Ding X . Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients—a combined diffusion tensor imaging and 1H-MR spectroscopy study. Am J Neuroradiol 2006; 27: 1426–1431.
  47. Wang PY, Kaufmann WE, Koth CW, Denckla MB, Barker PB . Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging. Ann Neurol 2000; 47: 477–484. · DOI
  48. Kreutzberg G . Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996; 19: 312–318. · DOI · Paper page
  49. Tsuchiya K, Hashimoto K, Iwata Y, Tsujii M, Sekine Y, Sugihira G et al. Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth. Biol Psychiatry 2007; 62: 1056–1058. · DOI
  50. Mori K, Hashimoto T, Harada M, Yoneda Y, Shimakawa S, Fujii E et al. Proton magnetic resonance spectroscopy of the autistic brain. No To Hattatsu 2001; 33: 329–335.

Cited by

See all 85

Metadata

Authors
Aoki, Y., Kasai, K., & Yamasue, H.
Venue
Translational Psychiatry
Published
2012-01-17
Volume
2
Issue
1
Pages
e69-e69
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2075621670
Cited by
85
References
12
FWCI
0.74
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.